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Abstract
The coordinated differentiation of myoblasts to mature muscle is essential for muscle development and repair, 
and study of the myogenic program in health and disease is critical to the understanding and treatment of 
muscle pathologies. Use of quantitative RT-PCR to analyse gene expression in cell culture models of muscle 
differentiation can be highly informative, but data must be normalized to one or more suitable reference genes. 
Myogenesis is highly dynamic, thus identification of genes with stable expression throughout this process is 
challenging. Establishing a common set of reference genes suitable for measuring expression in both healthy 
and disease models would be of considerable advantage. We measured expression of 11 candidate 
normalization genes (Cdc40, Htatsf1, Ap3d1, Csnk2a2, Fbxw2, Fbxo38, Pak1ip1, Zfp91, GAPDH, ActB, 18S) in 
three cell culture models of myogenesis (C2C12 , H2K2B4, and the dystrophic line H2KSF1). Strong and weak 
normalization candidates were identified using the software packages Bestkeeper, geNorm and Normfinder, 
then validated against several known myogenic markers (MyoD, myogenin, MEF2C, dystrophin). Our data show 
that Csnk2a2 and Ap3d1 are suitable for normalizing gene expression during differentiation in both healthy and 
dystrophic cell-culture models, and that the commonly-used reference standards 18S, ActB and GAPDH are 
exceptionally poor candidates.
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Introduction
Quantitative PCR (qPCR) is a powerful tool for measuring changes in gene expression quickly and affordably, 
exploiting the exponential nature of PCR to obtain straightforward numerical data from cDNA prepared using 
even very small amounts of starting mRNA. However the effects of inherent minor variations in sample 
preparation and handling, and variable efficiencies of RNA purification and cDNA synthesis1, can combine to 
produce significant alterations in measured values. To meaningfully interpret quantitative PCR data for a given 
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gene of interest the use of internal reference genes is therefore essential. Highly-expressed “housekeeping” 
markers such as beta-actin (ActB), GAPDH or 18S ribosomal RNA are widely employed, with the assumption 
that these markers remain constant for any given mRNA population within an experiment. There is growing 
evidence to suggest, however, that even these established markers may vary significantly under many 
experimental conditions, particularly those involving global changes in cell behaviour2,3,4 . Actin and GAPDH 
commonly exhibit strong stability at the protein level, but this stability is not necessarily a useful indicator of 
stability at the mRNA level, where turnover is inherently more dynamic. Use of ribosomal RNA or other non-
coding RNApolI/III transcripts carries further caveats, as these RNAs are often subject to different pathways of 
synthesis and degradation5,6, frequently exhibit extensive secondary structure (potentially impairing cDNA 
synthesis), are intrinsically linked to the rate of cellular activity, and -of critical relevance- comprise a 
disproportionately large fraction of total RNA (approx 80-95% depending on conditions7). As a consequence, 
changes in levels of these RNAs may mask or even exaggerate changes at the mRNA level, and thus are 
potentially poor choices for normalization.
To obtain quantitative PCR data of high confidence, it is thus sensible to assume there is no true “one size fits 
all” reference gene, and instead determine which genes exhibit the greatest stability for the experimental 
conditions in question. Use of multiple reference genes, preferably associated with independent cellular 
processes, is recommended: this increases confidence that any observed differences are accurate reflections of 
total mRNA levels rather than gene-specific perturbations due to experimental conditions.
Gene expression during myogenesis
Cell culture models of myogenesis are popular tools for the study of muscle development, repair and response 
to physiological and pharmacological agents. Progress though the myogenic program from proliferating 
myoblasts to terminally-differentiated myotubes necessitates major shifts in morphology and cellular activity: a 
complete cessation of the cell cycle, followed by cell migration and fusion into multinucleated myotubes (Fig 1). 
These subsequently mature through further fusion events, progressively lengthening, thickening and producing 
large quantities of contractile proteins, and ultimately are capable of developing spontaneous contractility. This 
process is likely to produce wide-ranging changes in gene expression, including those of metabolic and 
cytoskeletal components, members of which (GAPDH and beta-actin, respectively) are frequently selected as 
normalization genes. Selection of an appropriate set of reference genes under such a varied suite of conditions 
is thus non-trivial, yet nevertheless critical for accurate measurement of gene expression during myogenesis. A 
number of studies have identified candidate reference genes for use in studies of mature muscle (and in 
cultured, terminally-differentiated myotubes) in a range of species8,9,10,11,12 , though candidates for 
normalization of gene expression throughout the myogenic program (particularly in cell culture) are more 
limited13,14, and are generally specific to a single cell line. Furthermore, such studies typically use at most 5 or 
6 candidate genes (occasionally as few as 3), and do not necessarily validate the candidates identified against 
multiple genes with known expression patterns.
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Fig. 1: Progression through myogenesis
H2KSF1 myoblasts in proliferation medium (A), and 24, 48 and 72 hours after initiation of differentiation (B-
D, respectively). Mononucleated myoblasts (A) fuse to form multinucleated myotubes of increasing size 
(BCD).
We examined gene expression of a comparatively large set of putative reference genes throughout myogenic 
differentiation in two healthy and one disease-model murine cell culture systems: the commonly-used C2C12
myoblast line15 , and the immortomouse-derived myoblast lines H2K2B416 and H2KSF117 . The latter cell line 
(SF1) carries the mdx mutation (a premature termination codon in exon 23 of the dystrophin gene) and is thus 
a cell line model for dystrophic muscle.
We here present data suggesting a common set of candidates for normalizing gene expression during 
myogenesis in these three culture models of murine muscle differentiation.
For reference gene candidates, eleven genes were selected from the PrimerDesign geNormplus reference set (
Cdc40, Htatsf1, Ap3d1, Csnk2a2, Fbxw2, Fbxo38, Pak1ip1, Zfp91, GAPDH, ActB, 18S: selected based on 
their high stability in a large number of systems18 , Table 1). This set conveniently includes the three 
commonly used reference genes noted above, allowing direct assessment of their accuracy in a myogenic 
model. Relative expression values for the candidate genes were prepared and subsequently analysed for 
suitability using several freely available software packages: Bestkeeper19 , geNorm20 and Normfinder21 .
To test the efficacy of the genes identified, they were used to normalize measured expression levels of several 
genes known to change in a recognisable fashion throughout myogenesis (MyoD, myogenin, MEF2C and 
dystrophin).
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Table 1. Reference genes selected
The full names and functions of the geNormPlus genes used in this study
Gene Name Full Name Function
Cdc40 Cell Division Cycle 40/PRP17 Catalytic component of the spliceosome complex
Htatsf1 HIV-1 Tat Specific Factor Transcription factor, involved in transcriptional elongation
Ap3d1 Adapter-Related Protein Complex 3 Subunit
Non-clathrin associated subunit of the AP3 adaptor 
complex
Csnk2a2 Casein Kinase 2, Alpha Prime Polypeptide
Subunit of Casein Kinase 2, a Ser/Thr kinase involved in 
multiple cellular processes
Fbxw2 F-Box And WD-40 Domain-Containing Protein
Substrate-recognition component of the SCF (SKP1-CUL1-
F-box protein)-type E3 ubiquitin ligase complex
Fbxo38 F-Box Protein 38/MOKA Putative ubiquitin ligase
Pak1ip1 PAK1 Interacting Protein 1/PIP1/WDR84
Negative regulator of Pak1 kinase
Zfp91 Zinc Finger Protein 91/PZF Atypical E3 ubiquitin-protein ligase that mediates activatory ‘Lys-63′-linked ubiquitination of MAP3K14/NIK
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
Catalyses conversion of glyceraldehyde 3-phosphate to 3-
phospho glyceroyl phosphate
ActB Beta Actin Major component of the non-muscle cytoskeleton
18S 18S ribosomal RNA RNA component of the 40S ribosome
Experimental
Cell culture:
H2K2B4/SF1 cell lines are derived from immortomouse muscle, and are thus conditionally immortal, expressing 
a temperature-sensitive SV40 largeT antigen under the control of a gamma-interferon (γ-IFN)-inducible 
promoter. Cells were grown in matrigel-coated flasks (0.1mg.ml-1) and maintained in a proliferative state by 
incubation at 33°C in proliferation medium: DMEM+glutamax (invitrogen) supplemented with 20% (v/v) heat 
inactivated-foetal bovine serum, 2% (v/v) chicken embryo extract (CEE, Sera laboratories international), 1% 
(v/v) Penicillin/Streptomycin (Sigma, final concentration 100u.ml-1 penicillin, 100ug.ml-1 streptomycin), and 20 
U/mL γ-IFN (Chemicon). One day prior to differentiation, cells were seeded onto matrigel-coated 6-well plates at 
2×105 cells.well-1 (2B4) and 5×105 cells.well-1 (SF1), plating conditions established to allow optimal 
differentiation without under- or overcrowding cells. Differentiation was initiated by replacement of growth 
media with differentiation medium (DMEM+glutamax supplemented with 5% horse serum (PAA) and 1% 
pen/strep) and incubation at 37°C. Differentiation medium was partially replaced (50% of medium aspirated, 
replaced with fresh differentiation medium) after 5 days of differentiation.
C2C12 cells were grown in DMEM+glutamax supplemented with 10% bovine serum and 1% pen/strep. Prior to 
differentiation, cells were seeded onto 6-well plates and allowed to reach 80-90% confluency. Differentiation 
was initiated by replacement of growth media with differentiation medium (DMEM+glutamax supplemented 
with 2% horse serum and 1% pen/strep). Differentiation medium was partially replaced (see above) every two 
days.
Cells were harvested for RNA (see below) at the time of differentiation and at 24-hour intervals following, until 
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spontaneous contractility was observed by microscopy (between 144 and 168hours post-differentiation): 
contractile behaviour usually results in subsequent detachment from the plate surface, thus this was a 
necessary endpoint. Three replicate samples were collected per cell line, per time point.
QPCR Primers:
Sequences of reference gene primers (Cdc40, Htatsf1, Ap3d1, Csnk2a2, Fbxw2, Fbxo38, Pak1ip1, Zfp91, 
GAPDH, ActB) are proprietary property of PrimerDesign18 , but generate mouse-specific amplicons of 90-180bp. 
All other sequences are shown below. Primers to MyoD, myogenenin, MEF2C and dystrophin were designed 
using primer3 software version 0.4.0 (bioinfo.ut.ee/primer3-0.4.0/) to produce mouse-specific amplicons of 100-
220bp, spanning one or more exon/exon boundaries, with a preference for those spanning large introns to 
prevent amplification of trace genomic DNA carryover. 18S primer sequences were taken from Schmittgen et al3
. All primers had melting temperatures (Tm) of 58-61°C. Amplification of a single, specific band per primer pair 
was confirmed via conventional PCR for all primer pairs used.
Primer sequences: MyoD Fwd: TACAGTGGCGACTCAGATGC, MyoD Rev: GAGATGCGCTCCACTATGCT, myogenin 
Fwd: CTACAGGCCTTGCTCAGCTC, myogenin Rev: ACGATGGACGTAAGGGAGTG, MEF2C Fwd: 
GCCGGACAAACTCAGACATT, MEF2C Rev: TGGGATGGTAACTGGCATCT, dystrophin Fwd: 
GTGGGAAGAAGTAGAGGACTGTT, dystrophin Rev: AGGTCTAGGAGGCGTTTTCC, 18S Fwd: 
GTAACCCGTTGAACCCCATT, 18S Rev: CCATCCAATCGGTAGTAGCG
RNA isolation and cDNA synthesis:
Total RNA was isolated by addition of 100ul TRIzol (Fisher Scientific) to each well of cells, agitation with a cell 
scraper and transfer to a clean microcentrifuge tube. Phase-separation was initiated by addition of 30ul of 
chloroform and vortexing followed by centrifugation. Aqueous phases were collected and nuclease-free water 
added to a final volume of 500ul (for ease of manipulation), before two sequential chloroform extractions (1:1). 
RNA was precipitated by addition of 10ug glycogen (Roche), 50ul 3M NaAc pH 5.5, and 1.5ml ice-cold ethanol. 
Following incubation (1 hour, -80°C) RNA was collected by centrifugation, pellets were washed using ice-cold 
70% ethanol and dissolved in nuclease-free water. RNA integrity was established by gel electrophoresis and 
RNA purity by nanodrop spectroscopy. Acceptable samples displayed two clear ribosomal bands (indicating no 
degradation occured during isolation), 260/280 ratios > 2.0 and 260/230 ratios > 1.8. Samples with 260/230 
ratios below 1.8 (chiefly guanidium carryover, not uncommon when dealing with small TRIzol volumes) were 
diluted in nuclease-free water to a final volume of 500ul, extracted a second time with chloroform (1:1) and 
ethanol precipitated as before. This additional extraction reliably produced 260/230 ratios > 2.0, albeit with 
substantially reduced RNA yields. 1ug of total RNA was used for cDNA synthesis using the RTnanoscript kit 
(PrimerDesign) according to the manufacturers’ instructions, using both oligo dT and random 9mers as first-
strand synthesis primers. cDNA preparations were diluted 20-fold prior to quantitative PCR analysis, and the 
same preparations were used for all studies.
QPCR:
QPCR analyses used Brilliant II SYBR green mastermix (Agilent) or Precision SYBR green mastermix 
(PrimerDesign) in 384 well plates (white hard-shell thin wall, BioRad) with a CFX384 lightcycler (Biorad) using 
three-step cycling conditions. Reactions were performed in duplicate or triplicate in 10ul volumes using 1-3ul of 
diluted cDNA (see above: ca. 2-6ng cDNA assuming 1:1 synthesis) per well. Dilution series were performed to 
establish that residual cDNA synthesis reagents did not impair PCR efficiency at these dilutions. All runs 
included melt curve analysis and template-free controls to confirm specific, single-product amplification. All 
primer pairs produced single amplicons and reactions were of comparable efficiency (95-100%) as established 
by standard dilution curve and analysis of individual traces.
Quantification cycle (Cq) values were determined by regression analysis of the amplification traces. Average Cq 
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values for each replicate reaction were used either directly (BestKeeper) or internally normalized to a relative 
linear expression range (0-1) before analysis (Normfinder, geNorm). Samples exhibiting more than 10-fold 
deviation in relative expression from the dataset average in a majority of genes were typically excluded from 
analysis. Experimental normalizations using suitable candidates used the linearised expression data of the 
respective genes, or where multiple normalization genes were used, the geometric average of the linearised 
expression data.
Bestkeeper is available as a prepared excel spreadsheet file (obtained at http://www.gene-
quantification.de/bestkeeper.html) into which raw Cq data (from reference candidates and/or genes of interest) 
is entered, and pairwise comparisons and correlation coefficients are calculated automatically. Documentation 
is available at the download location. Normfinder is available as an excel plugin or as code formatted for R 
(obtained at http://moma.dk/normfinder-software). Documentation is available at the download location.
geNorm (as first released) is no longer freely available, having been integrated into the qBase software 
package (http://www.biogazelle.com/qbaseplus) however an office 2010-compatible copy of the original excel 
macro program is available at http://ulozto.net/xsFueHSA/genorm-v3-zip. All analysis in this manuscript was 
performed on a Windows 7 operating system using excel 2003 and excel 2010, and the authors cannot confirm 
Mac-compatibility of any of the above software packages.
Results and Discussion
Identification of suitable normalization genes presents a circular conundrum: how can one assess the stability of 
a given reference gene without a suitable reference gene for comparison? The three software packages 
employed utilise subtly different strategies to identify suitable reference genes:
Bestkeeper19 calculates a geometric average for the entire dataset provided, thus generating a 
hypothetical global normalization factor, the ‘bestkeeper’: taking the premise that as the number of genes 
measured increases, variations resulting from genuine biological changes in gene expression make 
progressively lower contributions to the overall trend than do global variations in cDNA concentration 
arising from sample preparation/handling. Thus, by making pairwise comparisons between expression data 
from individual genes and this ‘bestkeeper’ one can identify those with least variation, i.e. those that best 
reflect overall cDNA (thus mRNA) levels.
geNorm20 takes a similar approach; reasoning that highly-similar patterns of variation observed in genes 
associated with unrelated cellular processes (such as those supplied in the geNormPlus gene set) is more 
likely to reflect variation in cDNA levels than in gene expression. This technique thus utilises pairwise 
comparison to rank candidate genes by summed individual variation, then iteratively discards the most 
variant gene before repeating the analysis, thus identifying a pair of genes with minimum respective 
variation, and a ranked list of genes of increasing variance.
Normfinder21 (unlike the two methods above) does not make direct gene-to-gene comparisons, instead 
calculating individual variations for each gene relative to the dataset average, accounting for both 
intergroup (here, comparing different timepoints) and intragroup (comparing replicate timepoints) variation, 
summing these to provide a gene-specific stability value for a given set of conditions. This inclusion of 
group-specific analysis thus identifies genes that show the greatest overall stability over the conditions 
presented, rather than those that merely exhibit well-matched variation. The analysis provides both the 
best single candidate, and the best pair of genes (which may not include the best single candidate: two 
marginally less-stable genes that vary in opposing fashions may average to provide more stable reference 
data than a single gene alone).
Both Bestkeeper and geNorm place emphasis on pairwise techniques thus can potentially misattribute value to 
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groups of highly-variable genes with closely-matched expression patterns: co-ordinately regulated cell-cycle 
factors would score highly, despite being clearly variable. Furthermore, gene-to-gene comparison analysis is 
highly sensitive to the dataset presented: removal of a single high-scoring candidate lowers the correlation of 
similar high-scoring candidates, resulting in lower-ranked candidates demonstrating higher relative pairwise 
correlation, thus potentially ‘reshuffling’ the entire stability curve (similarly, inclusion of additional candidates 
may create new high-scoring pairings, with similar consequences). However, as pairwise analysis is essentially 
blind to overall apparent signal stability, these techniques are inherently tolerant of ‘messy’ datasets resulting 
from variable mRNA quality or cDNA synthesis.
Conversely, Normfinder avoids direct gene-to-gene comparison, instead focusing on individual gene stability: 
the analysis compares each gene individually to group-wide averages, and is thus inherently less sensitive to 
removal or addition of candidates. While calculating separate values of intragroup (replicate samples) and 
intergroup (treatment-to-treatment) variance allows estimates to be made of sample variability vs gene 
stability, this technique necessarily makes the assumption that the dataset averages do not exhibit systematic 
intergroup variation, and thus is potentially less suitable to datasets derived from samples undergoing 
progressive cellular alterations (such as the myogenic program).
By using all three techniques for this study, we aimed to minimise the limitations of any specific method while 
capitalising on the unique strengths of each approach. Furthermore (as these techniques benefit progressively 
from larger datasets) rather than four or five candidates as is common in the literature, eleven were used. This 
affords both greater confidence in suggested reference genes, and produces a greater range between those 
identified as good candidates and those as poor candidates. This latter aspect can be helpful to the researcher, 
as it is sometimes troubling to simply accept the output of a given mathematical algorithm (especially if the 
algorithm serves only to rank multiple apparently appropriate reference genes in order of preference). 
Identification of poor candidates that can be empirically demonstrated as such confers greater strength to the 
identification of good candidates.
geNorm analysis (see Fig 2) indicated only slight consensus on optimal normalization candidates between the 
three cell lines. However, as a commonly accepted threshold for average stability (M) is a value < 0.5, the 
analysis reveals that all normalization genes are potentially adequate candidates in C2C12s. Similarly 2B4 and 
SF1 cells, while exhibiting lower expression stability than C2C12 (i.e. greater M values), still present relatively 
few candidates failing to fall below the 0.5 threshold. Pak1ip1, Csnk2a2 and Ap3d1 rank relatively highly in 
all three cell lines, while other genes vary considerably in their relative stabilities. Of additional note, both 18S
and ActB rank very poorly in all lines, while GAPDH ranks highly in SF1 cells alone. geNorm additionally 
calculates the pairwise variation of normalization factors derived from increasing numbers of genes, allowing 
estimation of the number of control genes needed for optimal normalization: as a pairwise analysis, 2 genes is 
the minimum. Additional normalization genes may reduce variation, but this is not guaranteed, nor indeed 
always necessary. Values below 0.15-0.2 are generally accepted as sufficient20 , thus as shown in Fig 2 (lower 
panels) for all cell lines increasing the number of normalization genes from 2 to 3 is beneficial but unnecessary.
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Fig. 2: geNorm analysis
Upper panel: Genes ranked by their calculated average expression stabilities (stability increases from left to 
right) in C2C12, 2B4 and SF1 (left to right, respectively). Lower panel: optimal number of control genes for 
normalization for C2C12, 2B4 and SF1 (left to right, respectively). Charts compare pairwise variation V of 
normalization factors as number of factors used increases (n/n+1). V2/3 thus compares 2 genes with 3, 
V3/4: 3 genes with 4. Values below 0.15 are assumed to be sufficient, thus in all cases increasing the 
number of genes used beyond 2 is of limited benefit.
Normfinder analysis (Fig 3) confirmed that C2C12 cells exhibit greater overall expression stability than the 
immortomouse lines, and again Csnk2a2 and Ap3d1 scored highly in all lines. This analysis also produced 
greater consensus on suggested candidates, with Csnk2a2 universally being the highest scoring single-gene 
candidate. Furthermore, 18S, ActB and (to a lesser extent) GAPDH were again shown to be candidates 
exhibiting poor stability.
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Fig. 3: Normfinder analysis
Genes ranked by stability value (summed inter and intra-group stability -Stability increases from left to 
right) in C2C12, 2B4 and SF1 (left to right, respectively). Suggested candidates and derived stability values 
for single reference gene or reference gene combination are indicated.
Bestkeeper analysis was largely in agreement with the above two methods: while the bestkeeper method 
generates a substantial amount of data (including individual gene variances and systematic pairwise 
comparisons between each gene), the most useful output measure for this study is the generation of a global 
normalization factor derived from the entire dataset (the ‘bestkeeper’) and the Pearson correlation coefficients 
between each gene and this factor: simply, the degree to which individual genes agree with this calculated 
global value. As shown in Fig 4, Csnk2a2 and Ap3d1 show high degrees of correlation in all three cell lines, 
and 18S, ActB and GAPDH perform poorly. Of particular note is the markedly poor scoring of 18S in SF1 and 
C2C12 cells, highlighting the risk of using ribosomal RNA as a standard for messenger RNA. Examination of the 
raw expression data reveals that while levels of 18S RNA are comparatively consistent -at most a 2-fold 
variation between highest and lowest signal- (as might be expected given initial amounts of RNA for cDNA 
synthesis are based on total RNA, which is primarily ribosomal), these levels correlate very poorly with 
expression data from every messenger RNA measured. Conversely, the relative levels of mRNAs in the dataset 
correlate strongly with each other: ribosomal RNA and messenger RNA do not strongly correlate, and should not 
be considered to be coupled.
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Fig. 4: Bestkeeper analysis
Genes ranked by increasing Pearson correlation coefficient (r) with the bestkeeper values (a series derived 
from the geometric average of all candidate gene series). Correlation increases from left to right.
Taking these data as a whole, it is tempting (albeit mathematically unsound) to simply sum the data from these 
three analyses to obtain a ‘consensus’ panel of suitable reference genes. However as noted above each 
analysis method employs differing approaches, and the confidence of the respective results returned will vary 
depending on the innate variability of the dataset presented. For example, a gene exhibiting very little variation 
from the dataset average across all timepoints and replicates would score highly via Normfinder, but (assuming 
this stability was unique to a single gene in the dataset) would score poorly via geNorm due to lack of a suitable 
pairwise match. Nevertheless, if a given gene consistently scores highly in all three analyses, and indeed scores 
highly in all three cell lines, it is likely to be a strong candidate.
A more practical test of the suitability of a given suggested reference gene therefore is an empirical one: at the 
most basic, one can simply examine the raw expression data for the genes in question. While these data are (by 
definition) not normalized and thus highly noisy, a differentiation-related trend observable even at this early 
stage would certainly call into question the suitability of a given genes as a normalization candidate, 
particularly if such a trend was observed in multiple cell lines. As shown in Fig 5, in all cell lines (albeit to a 
lower extent in C2C12, where the variation of the entire dataset is lower) ActB exhibits a differentiation-
correlated decline in expression even when analysed as raw data, while in contrast the expression of the high-
scoring candidate Csnk2a2 does not show any significant trend.
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Fig. 5: Csnk2a2 vs ActB : raw expression data
Cq values from Csnk2a2 and ActB expression transformed to a linear range, plotted as means (+standard 
deviations) of experimental replicates from each timepoint (indicated). Csnk2a2 expression (white bars, top) 
shows no clear trend. ActB expression (grey bars, bottom) declines progressively throughout differentiation.
To assess the efficacy of the candidate reference genes we measured expression of several genes known to 
vary over the course of myogenic differentiation, and examined the data without normalization, or normalized 
using either a strong (Csnk2a2) or weak candidate (ActB). Note that it is advisable to use the geometric 
average of several appropriate reference genes for normalization: we have used single gene normalizations 
here to contrast strong and weak candidates -though the authors note that in this instance, combining Csnk2a2
with a second high scoring candidate (Ap3d1) gave minimal improvement from Csnk2a2 alone 
(supplementary figure 3).
As shown in figures 6 and 7 and supplementary figures 1 and 2, both the high-scoring Csnk2a2 and the low-
scoring ActB were often similarly effective in lowering errors within a given timepoint (i.e. normalizing data 
between replicates). This is to be expected: normalizing expression to any mRNA will tend to stabilise apparent 
signal within a given timepoint regardless of the temporal relationship between mRNAs over the course of 
differentiation. However, as predicted by the raw analysis above, normalizing using ActB produced significantly 
higher fold changes: consistently lowering apparent early expression signal while concomitantly raising late 
expression. This is demonstrated particularly effectively via dystrophin expression (Fig 6): the late-
differentiation marker dystrophin is an exceptionally large gene (taking ca. 16 hours to fully transcribe) and is 
spliced co-transcriptionally22 . Using a primer set designed to early sequence (the primers used for this study 
span exons 1-3) will thus detect both completed transcripts and those mid-synthesis. Correspondingly, as 
dystrophin transcripts in the dystrophic cell line (SF1) will be subject to nonsense-mediated decay, expression in 
these cells should effectively reflect mid-synthesis transcripts only. Using Csnk2a2 to normalize expression 
data, both C2C12 and H2K2B4 cells show an approximately 5-fold increase in dystrophin expression, compared 
with only 3-fold in SF1 cells, as might reasonably be expected. Furthermore, dystrophin expression appears to 
plateau by day 4-6 (earlier in 2B4/SF1, later in C2C12). Employing ActB as a reference instead results in a less-
plausible 10, 25 and 14-fold increase in dystrophin expression in C2C12, 2B4 and SF1 respectively, including a 
dramatic but physiologically unlikely 2-fold spike in expression between day 6 and 7 in 2B4 cells. Similarly 
Mef2C, a gene activated early in differentiation23 (Fig 7) normalized using Csnk2a2 peaks sharply at an 
approximately 10 to 12-fold increase in all cell lines (again peaking roughly 2 days later in C2C12), whereas 
when normalized using ActB, expression increases 20 to 50 fold with no clear consensus between cell lines. 
Similar results were observed for myogenin and MyoD (supplementary figures 1 and 2), though the authors note 
11PLOS Currents Muscular Dystrophy
that under these condition MyoD expression appears to change very little in C2C12 cells: indeed myogenic 
changes in expression as a whole appear to occur earlier, and more dramatically, in the H2K lines than in C2C12 
cells. This likely reflects the more synchronised commitment to differentiation effected by the temperature shift 
and interferon withdrawal protocol used with immortomouse cells (resulting in a more homogenous cell 
population).
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Fig. 6: Dystrophin expression
Relative dystrophin expression levels in C2C12 (left) 2B4 (centre) and SF1 (right) cell lines. Data expressed 
as means (+standard deviations) of linearised values for raw data (black bars), or raw data normalized using 
Csnk2a2 (white bars) or ActB (grey bars). All data presented as fold change from undifferentiated (day 0) 
expression level.
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Fig. 7: Mef2C expression
Relative Mef2C expression levels in C2C12 (left) 2B4 (centre) and SF1 (right) cell lines. Data expressed as 
means (+standard deviations) of linearised values for raw data (black bars), or raw data normalized using 
Csnk2a2 (white bars) or ActB (grey bars). All data presented as fold change from undifferentiated (day 0) 
expression level.
Conclusion
The data presented here suggest Csnk2a2 is a strong candidate for normalizing expression data throughout 
myogenesis in cell culture, in both healthy and dystrophic models. Ap3d1 also scores highly and would thus 
serve as a suitable additional reference gene, however for this study we found that Csnk2a2 alone was 
sufficient. A number of genes appeared to show cell-line specific behaviour: Fbxo38 and Pak1ip1 both score 
highly in immortomouse lines (2B4, SF1) yet poorly in C2C12, while Zfp91 exhibits the reverse. Similarly, some 
genes appear to be sensitive to disease-state: Cdc40 scores highly in healthy cells (2B4, C2C12) and poorly in 
the dystrophic cell line SF1. Finally, in all cases 18S RNA demonstrated low correlation with mRNA levels, 
suggesting that (in contrast to other cell culture studies) for normalizing expression during in vitro myogenesis, 
use of this ribosomal subunit as a reference is not recommended. Within the messenger RNAs, beta actin (ActB
) scored consistently poorly, and indeed demonstrated a strong differentiation-correlated decrease in 
expression. The third commonly-cited reference gene GAPDH scored marginally higher, though still 
comparatively poorly: analysis of the raw data (supplementary figure 4) indicates GAPDH expression increases 
markedly over the first 4 days of differentiation.
It should be noted that along with 18S RNA (which comprises a large fraction of total RNA) both ActB and 
GAPDH mRNAs are present at substantially higher levels than the other reference genes investigated: indeed 
in the case of GAPDH by two orders of magnitude (supplementary table 1). While expression levels of the 
myogenic genes used in this study cover a substantial range (with myogenin and MyoD present at levels over 
100 times greater than dystrophin) and vary markedly throughout myogenic differentiation, relative levels of 
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these genes are more closely matched by Csnk2a2 and Ap3d1 than by GAPDH or 18S (supplementary figure 
5). This is advantageous, as abundant transcripts (GAPDH, ActB) are readily detected even in samples 
prepared from poor quality RNA, where genes of interest may no longer be detectable. Use of reference genes 
sharing a similar expression level to genes of interest affords more confidence to any detected signals, and will 
more readily highlight any deficiencies in sample preparation/handling.
Taken together, these data demonstrate the unreliability of 18S, ActB and GAPDH as universal reference 
genes and illustrate the importance of determining optimal reference genes for any given set of experimental 
conditions. We show that use of multiple analysis methods with a relatively large panel of candidates allows the 
identification of appropriate reference genes even in highly dynamic biological scenarios, and that Csnk2a2 
and Ap3d1 are suitable for normalizing gene expression during in vitro myogenesis in both healthy and 
dystrophic cells.
APPENDIX 1
Supplementary Data
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Fig. 1: MyoD expression
Relative MyoD expression levels in C2C12 (left) 2B4 (centre) and SF1 (right) cell lines. Data expressed as 
means (+standard deviations) of linearised values for raw data (black bars), or raw data normalized using 
Csnk2a2 (white bars) or ActB (grey bars). All data presented as fold change from undifferentiated (day 0) 
expression level.
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Fig. 2: Myogenin expression
Relative Myogenin expression levels in C2C12 (left) 2B4 (centre) and SF1 (right) cell lines. Data expressed 
as means (+standard deviations) of linearised values for raw data (black bars), or raw data normalized using 
Csnk2a2 (white bars) or ActB (grey bars). All data presented as fold change from undifferentiated (day 0) 
expression level.
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Fig. 3: Normalizing with Csnk2a2 alone vs Csnk2a2 and Ap3d1
Relative expression levels of dystrophin, MEF2C, MyoD and myogenin (left to right) in C2C12 (top) 2B4 
(middle) and SF1 (bottom) cell lines, normalized to Csnk2a2 (white bars) or to the geometric average of 
Csnk2a2 and Ap3d1 (grey bars). Data expressed as means +standard deviations. All data presented as fold 
change from undifferentiated (day 0) expression level.
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Fig. 4: GAPDH raw expression data
Cq values from GAPDH expression transformed to a linear range, plotted as means (+standard deviations) 
of experimental replicates from each timepoint (indicated).
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Mean Cq values
Arithmetic means of Cq values from the eleven reference genes and four myogenic genes used in this study, in the 
three cell lines investigated. All Cq values were below 30.
  H2K2B4 H2KSF1 C2C12
Cdc40 24.4 24.45 24.22
Csnk2a2 23.45 23.25 22.38
Zfp91 25.93 23.34 22.98
Pak1ip1 24.05 23.82 23.86
Htatsf1 25.44 25.07 24.58
Fbxw2 24.38 24.16 23.71
Fbxo38 26.05 25.06 25.09
Ap3d1 23.06 22.6 22.63
GAPDH 16.8 16.28 16.59
ActB 19.85 18.94 18.3
18S 13.01 12.18 12.86
MyoD 20.94 20.29 23.3
Dystrophin 26.87 27.5 27.04
Mef2C 23.04 22.37 24.14
Myogenin 20.23 19.53 20.34
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Fig. 5: Relative expression ranges
Representative expression levels of the genes used in this study. Midlines indicate mean expression level, 
highest and lowest levels detected for each gene indicated by bounding box. Expression is calculated as fold 
change relative to the lowest detected signal (dystrophin), and is displayed on a log(10) scale. Reference 
genes are displayed in light grey, myogenic genes in dark grey. Top panel: 2B4. Middle panel: SF1. Lower 
panel: C2C12.
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